CrossRef Cited-by Linking Search Results

This Article:

has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking:

  • Glutamate Promotes Cell Growth by EGFR Signaling on U-87MG Human Glioblastoma Cell Line
    Daniel Pretto Schunemann, Ivana Grivicich, Andréa Regner, Lisiane Freitas Leal, Daniela Romani de Araújo, Geraldo Pereira Jotz, Carlos Alexandre Fedrigo, Daniel Simon, and Adriana Brondani da Rocha
    Pathology & Oncology Research (2010) 16 :285
  • Targeting the ERBB family in cancer: couples therapy
    Niall Tebbutt, Mikkel W. Pedersen, and Terrance G. Johns
    Nature Reviews Cancer (2013) 13 :663
  • EGF receptor activation under the action of lipopolysaccharide on human A431 carcinoma cells
    A. L. Evdonin, I. V. Kropacheva, N. N. Nikolsky, and N. D. Medvedeva
    Doklady Biological Sciences (2010) 431 :159
  • EGFR inhibitor enhances cisplatin sensitivity of human glioma cells
    Yan Zhang, Xihong Xing, Hongfeng Zhan, Qiaoyu Li, Yu Fan, Liping Zhan, Qiang Yu, and Jian Chen
    Journal of Huazhong University of Science and Technology [Medical Sciences] (2011) 31 :773
  • Molecular recognition of HER-1 in whole-blood samples
    Iuliana Moldoveanu, Camelia Stanciu Gavan, and Raluca-Ioana Stefan-van Staden
    Journal of Molecular Recognition (2014) 27 :653
  • Src-dependent Phosphorylation of the Epidermal Growth Factor Receptor on Tyrosine 845 Is Required for Zinc-induced Ras Activation
    Weidong Wu, Lee M. Graves, Gordon N. Gill, Sarah J. Parsons, and James M. Samet
    Journal of Biological Chemistry (2002) 277 :24252
  • Nox1 transactivation of epidermal growth factor receptor promotes N-cadherin shedding and smooth muscle cell migration
    Dammanahalli K. Jagadeesha, Maysam Takapoo, Botond Banfi, Ramesh C. Bhalla, and Francis J. Miller
    Cardiovascular Research (2012) 93 :406
  • Cetuximab-resistant oral squamous cell carcinoma cells become sensitive in anchorage-independent culture conditions through the activation of the EGFR/AKT pathway
    International Journal of Oncology (2015) 47 :2165
  • Plant stanols induce intestinal tumor formation by up-regulating Wnt and EGFR signaling in ApcMin mice
    Maija Marttinen, Essi Päivärinta, Markus Storvik, Laura Huikko, Heli Luoma-Halkola, Vieno Piironen, Anne-Maria Pajari, and Marja Mutanen
    The Journal of Nutritional Biochemistry (2013) 24 :343
  • Signal transduction of MEK/ERK and PI3K/Akt activation by hypoxia/reoxygenation in renal epithelial cells
    Dae Sik Kwon, Chae Hwa Kwon, Jae Ho Kim, Jae Suk Woo, Jin Sup Jung, and Yong Keun Kim
    European Journal of Cell Biology (2006) 85 :1189
  • Role of epidermal growth factor receptor in malignant pleural mesothelioma and its value for successful chemical pleurodesis
    A. El-Hosainy, H. Hosny, S. Gabal, S. Ahmed, and Y. El-Hinnawy
    Egyptian Journal of Chest Diseases and Tuberculosis (2014) 63 :873
  • TGF-β transactivates EGFR and facilitates breast cancer migration and invasion through canonical Smad3 and ERK/Sp1 signaling pathways
    Yuanyuan Zhao, Jing Ma, Yanling Fan, Zhiyong Wang, Ran Tian, Wei Ji, Fei Zhang, and Ruifang Niu
    Molecular Oncology (2018) 12 :305
  • HER3, serious partner in crime
    Arjan Kol, Anton G.T. Terwisscha van Scheltinga, Hetty Timmer-Bosscha, Laetitia E. Lamberts, Frederike Bensch, Elisabeth G.E. de Vries, and Carolina P. Schröder
    Pharmacology & Therapeutics (2014) 143 :1
  • Matrix Metalloproteinases 2 and 9 Mediate Epidermal Growth Factor Receptor Transactivation by Gonadotropin-releasing Hormone
    Susanne Roelle, Robert Grosse, Achim Aigner, H. W. Krell, Frank Czubayko, and Thomas Gudermann
    Journal of Biological Chemistry (2003) 278 :47307
  • Characterisation of HER heterodimers in breast cancer using in situ proximity ligation assay
    Fabrício F. T. Barros, Tarek M. A. Abdel-Fatah, Paul Moseley, Christopher C. Nolan, Alice C. Durham, Emad A. Rakha, Stephen Chan, Ian O. Ellis, and Andrew R. Green
    Breast Cancer Research and Treatment (2014) 144 :273
  • Cetuximab and Cisplatin Show Different Combination Effect in Nasopharyngeal Carcinoma Cells Lines via Inactivation of EGFR/AKT Signaling Pathway
    Jiajia Gu, Li Yin, Jing Wu, Nan Zhang, Teng Huang, Kai Ding, Haixia Cao, Lin Xu, and Xia He
    Biochemistry Research International (2016) 2016 :1
  • Comparison of delphinidin, quercetin and (–)‐epigallocatechin‐3‐gallate as inhibitors of the EGFR and the ErbB2 receptor phosphorylation
    Diana Fridrich, Nicole Teller, Melanie Esselen, Gudrun Pahlke, and Doris Marko
    Molecular Nutrition & Food Research (2008) 52 :815
  • Fatty Acid-binding Protein 5 and PPARβ/δ Are Critical Mediators of Epidermal Growth Factor Receptor-induced Carcinoma Cell Growth
    Padmamalini Kannan-Thulasiraman, Darcie D. Seachrist, Ganapati H. Mahabeleshwar, Mukesh K. Jain, and Noa Noy
    Journal of Biological Chemistry (2010) 285 :19106
  • Furanodienone induces cell cycle arrest and apoptosis by suppressing EGFR/HER2 signaling in HER2-overexpressing human breast cancer cells
    Ying-Wei Li, Guo-Yuan Zhu, Xiao-Ling Shen, Jian-Hong Chu, Zhi-Ling Yu, and Wang-Fun Fong
    Cancer Chemotherapy and Pharmacology (2011) 68 :1315
  • The EGFR Polymorphism rs884419 is Associated With Freedom From Recurrence in Patients With Resected Prostate Cancer
    Carmen A. Perez, Heidi Chen, Yu Shyr, Regina Courtney, Wei Zheng, Qiuyin Cai, Misun Hwang, Jerry Jaboin, Stephen Schleicher, Luigi Moretti, Marcia Wills, Joseph A. Smith, and Bo Lu
    The Journal of Urology (2010) 183 :2062
  • AKT induces senescence in primary esophageal epithelial cells but is permissive for differentiation as revealed in organotypic culture
    K Oyama, T Okawa, H Nakagawa, M Takaoka, C D Andl, S-H Kim, A Klein-Szanto, J A Diehl, M Herlyn, W El-Deiry, and A K Rustgi
    Oncogene (2007) 26 :2353
  • Heregulin-β promotes matrix metalloproteinase-7 expression via HER2-mediated AP-1 activation in MCF-7 cells
    Guogang Yuan, Lu Qian, Lun Song, Ming Shi, Dan Li, Ming Yu, Meiru Hu, Beifen Shen, and Ning Guo
    Molecular and Cellular Biochemistry (2008) 318 :73
  • Studies on epidermal growth factor receptor signaling in vertebrate limb patterning
    Minoru Omi, Melanie Fisher, Nita J. Maihle, and Caroline N. Dealy
    Developmental Dynamics (2005) 233 :288
  • Epidermal Growth Factor Receptor Is a Critical Mediator of Ultraviolet B Irradiation-Induced Signal Transduction in Immortalized Human Keratinocyte HaCaT Cells
    Yiru Xu, John J. Voorhees, and Gary J. Fisher
    The American Journal of Pathology (2006) 169 :823
  • Protein tyrosine kinase Syk modulates EGFR signalling in human mammary epithelial cells
    Anja Ruschel and Axel Ullrich
    Cellular Signalling (2004) 16 :1249
  • Analysis of activated EGFR signalling pathways and their relation to laminin-5 γ2 chain expression in oral squamous cell carcinoma (OSCC)
    Petra Richter, Frank D. Böhmer, Winfried Hindermann, Laura Borsi, Peter Hyckel, Peter Schleier, Detlef Katenkamp, Hartwig Kosmehl, and Alexander Berndt
    Histochemistry and Cell Biology (2005) 124 :151
  • A phase I trial of the trifunctional anti Her2 × anti CD3 antibody ertumaxomab in patients with advanced solid tumors
    N. Haense, A. Atmaca, C. Pauligk, K. Steinmetz, F. Marmé, G. M. Haag, M. Rieger, O. G. Ottmann, P. Ruf, H. Lindhofer, and S.-E. Al-Batran
    BMC Cancer (2016) 16 :
  • Tumor Cell Purging by Ex Vivo Expansion of Hemopoietic Stem Cells from Breast Cancer Patients Combined with Targeting ErbB Receptors
    Francesco Leone, Giuliana Cavalloni, Monica Gunetti, Ymera Pignochino, Wanda Piacibello, and Massimo Aglietta
    Biology of Blood and Marrow Transplantation (2006) 12 :68
  • Control of ErbB signaling through metalloprotease mediated ectodomain shedding of EGF-like factors
    Michael P. Sanderson, Peter J. Dempsey, and Andrew J. Dunbar
    Growth Factors (2006) 24 :121
  • Expression of estrogen receptors (ER) and human epidermal growth factor receptor 2 (HER2) in mucoepidermoid carcinoma: Relationship to its grading
    R.H. El-Attar and E.M. Deraz
    Tanta Dental Journal (2014) 11 :194
  • Caveolin-1-mediated Japanese encephalitis virus entry requires a two-step regulation of actin reorganization
    Qingqiang Xu, Mingmei Cao, Hongyuan Song, Shenglin Chen, Xijing Qian, Ping Zhao, Hao Ren, Hailin Tang, Yan Wang, Youheng Wei, Yongzhe Zhu, and Zhongtian Qi
    Future Microbiology (2016) 11 :1227
  • Effects of flavocoxid, a dual inhibitor of COX and 5-lipoxygenase enzymes, on benign prostatic hyperplasia
    D Altavilla, L Minutoli, F Polito, N Irrera, S Arena, C Magno, M Rinaldi, BP Burnett, F Squadrito, and A Bitto
    British Journal of Pharmacology (2012) 167 :95
  • β-Arrestin 1’s Interaction with TC45 Attenuates Stat signaling by dephosphorylating Stat to inhibit antimicrobial peptide expression
    Jie-Jie Sun, Hui-Ting Yang, Guo-Juan Niu, Xiao-Wu Feng, Jiang-Feng Lan, Xiao-Fan Zhao, and Jin-Xing Wang
    Scientific Reports (2016) 6 :
  • Clinical Significance of Epidermal Growth Factor Receptors in Non-small Cell Lung Cancer and a Prognostic Role for HER2 Gene Copy Number in Female Patients
    Samer Al-Saad, Khalid Al-Shibli, Tom Donnem, Sigve Andersen, Roy M Bremnes, and Lill-Tove Busund
    Journal of Thoracic Oncology (2010) 5 :1536
  • Cetuximab inhibits oral squamous cell carcinoma invasion and metastasis via degradation of epidermal growth factor receptor
    Wei Dai, Yanshu Li, Qing Zhou, Zhongfei Xu, Changfu Sun, Xuexin Tan, and Li Lu
    Journal of Oral Pathology & Medicine (2014) 43 :250
  • Increase in IkappaB kinase alpha expression suppresses the tumor progression and improves the prognosis for nasopharyngeal carcinoma
    Ling Deng, Yan Li, Ping Ai, Yuxin Xie, Hong Zhu, and Nianyong Chen
    Molecular Carcinogenesis (2015) 54 :156
  • Disruption of STAT3 signaling leads to tumor cell invasion through alterations of homotypic cell–cell adhesion complexes
    Christine Rivat, Olivier De Wever, Erik Bruyneel, Marc Mareel, Christian Gespach, and Samir Attoub
    Oncogene (2004) 23 :3317
  • Androgen-Independent Prostate Cancer: Potential Role of Androgen and ErbB Receptor Signal Transduction Crosstalk
    Soha Salama El Sheikh, Jan Domin, Paul Abel, Gordon Stamp, and El-Nasir Lalani
    Neoplasia (2003) 5 :99
  • GdX/UBL4A Specifically Stabilizes the TC45/STAT3 Association and Promotes Dephosphorylation of STAT3 to Repress Tumorigenesis
    Yangmeng Wang, Hongxiu Ning, Fangli Ren, Yuanjiang Zhang, Yu Rong, Yinyin Wang, Fuqin Su, Chenguang Cai, Zhe Jin, Zhiyong Li, Xinqi Gong, Yonggong Zhai, Dianjun Wang, Baoqing Jia, Ying Qiu, Yasuhiko Tomita, Joseph J.Y. Sung, Jun Yu, David M. Irwin, Xiao Yang, Xinyuan Fu, Y. Eugene Chin, and Zhijie Chang
    Molecular Cell (2014) 53 :752
  • Epidermal Growth Factor Protects Squamous Cell Carcinoma against Cisplatin-Induced Cytotoxicity through Increased Interleukin-1β Expression
    Shian-Chin Ko, Chi-Ruei Huang, Jiunn-Min Shieh, Jhen-Hong Yang, Wen-Chang Chang, Ben-Kuen Chen, and Spencer B. Gibson
    PLoS ONE (2013) 8 :e55795
  • Stress and Radiation-Induced Activation of Multiple Intracellular Signaling Pathways1
    Paul Dent, Adly Yacoub, Joseph Contessa, Ruben Caron, George Amorino, Kristoffer Valerie, Michael P. Hagan, Steven Grant, and Rupert Schmidt-Ullrich
    Radiation Research (2003) 159 :283
  • The Neural Cell Adhesion Molecule and Epidermal Growth Factor Receptor: Signaling Crosstalk
    Gro Klitgaard Povlsen
    Neurochemical Research (2008) :
  • Cetuximab induces mitochondrial translocalization of EGFRvIII, but not EGFR: involvement of mitochondria in tumor drug resistance?
    Agnieszka Dreier, Stefan Barth, Anand Goswami, and Joachim Weis
    Tumor Biology (2012) 33 :85
  • The impact of EGFR mutations on gefitinib sensitivity in non-small cell lung cancer
    Takeshi Suzuki, Tetsuya Mitsudomi, and Toyoaki Hida
    Personalized Medicine (2004) 1 :27
  • The importance of immunohistochemical expression of EGFr in squamous cell carcinoma of the oral cavity treated with surgery and postoperative radiotherapy
    Ernst J. Smid, T. Rianne Stoter, Elisabeth Bloemena, M. Vincent M. Lafleur, C. René Leemans, Isaac van der Waal, Ben J. Slotman, and Johannes A. Langendijk
    International Journal of Radiation Oncology*Biology*Physics (2006) 65 :1323
  • Changing strategies for target therapy in gastric cancer
    Suk-young Lee
    World Journal of Gastroenterology (2016) 22 :1179
  • The EGF Receptor and HER2 Participate in TNF-α-Dependent MAPK Activation and IL-8 Secretion in Intestinal Epithelial Cells
    Humberto B. Jijon, Andre Buret, Christina L. Hirota, Morley D. Hollenberg, and Paul L. Beck
    Mediators of Inflammation (2012) 2012 :1
  • ADAM-17/Tumor Necrosis Factor-α-Converting Enzyme Inhibits Neurogenesis and Promotes Gliogenesis from Neural Stem Cells
    Carmen Romero-Grimaldi, Maribel Murillo-Carretero, Miguel Angel López-Toledano, Manuel Carrasco, Carmen Castro, and Carmen Estrada
    STEM CELLS (2011) 29 :1628
  • Heparin-binding EGF-like growth factor regulates elastin and FGF-2 expression in pulmonary fibroblasts
    Jianghuai Liu, Celeste B. Rich, Jo Ann Buczek-Thomas, Matthew A. Nugent, Mikhail P. Panchenko, and Judith Ann Foster
    American Journal of Physiology-Lung Cellular and Molecular Physiology (2003) 285 :L1106
  • Stromal cell-derived factor-1α (SDF-1α/CXCL12) stimulates ovarian cancer cell growth through the EGF receptor transactivation
    Carola Porcile, Adriana Bajetto, Federica Barbieri, Simone Barbero, Rudy Bonavia, Marianna Biglieri, Paolo Pirani, Tullio Florio, and Gennaro Schettini
    Experimental Cell Research (2005) 308 :241
  • An imbalance in Akt/mTOR is involved in the apoptotic and acantholytic processes in a mouse model of pemphigus vulgaris
    Maider Pretel, Agustín España, Miren Marquina, Beatriz Pelacho, Jose María López-Picazo, and Maria J. López-Zabalza
    Experimental Dermatology (2009) 18 :771
  • Modeling the Effects of HER/ErbB1-3 Coexpression on Receptor Dimerization and Biological Response
    Harish Shankaran, H. Steven Wiley, and Haluk Resat
    Biophysical Journal (2006) 90 :3993
  • EGF receptor activation by GPCRs: An universal pathway reveals different versions
    Claus Liebmann
    Molecular and Cellular Endocrinology (2011) 331 :222
  • Inhibition of phosphatidylinositol 3-kinase signaling negates the growth advantage imparted by a mutant epidermal growth factor receptor on human glioblastoma cells
    Manuela Klingler-Hoffmann, Patricia Bukczynska, and Tony Tiganis
    International Journal of Cancer (2003) 105 :331
  • Requirement for ErbB2/ErbB signaling in developing cartilage and bone
    Melanie C. Fisher, Gail M. Clinton, Nita J. Maihle, and Caroline N. Dealy
    Development, Growth & Differentiation (2007) 49 :503
  • Orthovanadate-induced vasocontraction is mediated by the activation of Rho-kinase through Src-dependent transactivation of epidermal growth factor receptor
    Katsutoshi Yayama, Tomoya Sasahara, Hisaaki Ohba, Ayaka Funasaka, and Hiroshi Okamoto
    Pharmacology Research & Perspectives (2014) 2 :e00039
  • PML involvement in the p73-mediated E1A-induced suppression of EGFR and induction of apoptosis in head and neck cancers
    P Klanrit, P Taebunpakul, M B Flinterman, E W Odell, M A Riaz, G Melino, P Salomoni, J S Mymryk, J Gäken, F Farzaneh, and M Tavassoli
    Oncogene (2009) 28 :3499
  • Evaluation of radiolabeled ML04, a putative irreversible inhibitor of epidermal growth factor receptor, as a bioprobe for PET imaging of EGFR-overexpressing tumors
    Galith Abourbeh, Samar Dissoki, Orit Jacobson, Amir Litchi, Revital Ben Daniel, Desirediu Laki, Alexander Levitzki, and Eyal Mishani
    Nuclear Medicine and Biology (2007) 34 :55
  • HER2 Testing in Breast Cancer: Opportunities and Challenges
    Annette Lebeau
    Breast Care (2006) 1 :69
  • Down-regulation of epidermal growth factor receptor-dependent signaling by Porphyromonas gingivalis lipopolysaccharide in life-expanded human gingival fibroblasts
    B. H. Quinchia-Rios, M. Guerrero, S. Abozeid, B. Bainbridge, R. Darveau, T. Compton, and P. J. Bertics
    Journal of Periodontal Research (2008) 43 :290
  • 15-Deoxy-Δ12,14-prostaglandin J2 and thiazolidinediones transactivate epidermal growth factor and platelet-derived growth factor receptors in vascular smooth muscle cells
    Toshihiro Ichiki, Tomotake Tokunou, Kae Fukuyama, Naoko Iino, Satoko Masuda, and Akira Takeshita
    Biochemical and Biophysical Research Communications (2004) 323 :402
  • Understanding the HER family in breast cancer: interaction with ligands, dimerization and treatments
    Fabrício F T Barros, Desmond G Powe, Ian O Ellis, and Andrew R Green
    Histopathology (2010) 56 :560
  • The E3 ubiquitin ligase NEDD4 mediates cell migration signaling of EGFR in lung cancer cells
    Genbao Shao, Ranran Wang, Aiqin Sun, Jing Wei, Ke Peng, Qian Dai, Wannian Yang, and Qiong Lin
    Molecular Cancer (2018) 17 :
  • Spatial regulation of controlled bioactive factor delivery for bone tissue engineering
    Julia E. Samorezov and Eben Alsberg
    Advanced Drug Delivery Reviews (2015) 84 :45
  • Update on HER-2 as a target for cancer therapy: Alternative strategies for targeting the epidermal growth factor system in cancer
    William J Gullick
    Breast Cancer Research (2001) 3 :
  • Role of proneuregulin 1 cleavage and human epidermal growth factor receptor activation in hypertonic aquaporin induction
    A. Herrlich, V. Leitch, and L. S. King
    Proceedings of the National Academy of Sciences (2004) 101 :15799
  • Heparin-binding epidermal growth factor and Src family kinases in proliferation of renal epithelial cells
    Shougang Zhuang, Gilbert R. Kinsey, Kyle Rasbach, and Rick G. Schnellmann
    American Journal of Physiology-Renal Physiology (2008) 294 :F459
  • Human papillomavirus 16 E2 interacts with neuregulin receptor degradation protein 1 affecting ErbB-3 expression in vitro and in clinical samples of cervical lesions
    Francesca Paolini, Gianfranca Curzio, Elisa Melucci, Irene Terrenato, Barbara Antoniani, Mariantonia Carosi, Marcella Mottolese, Patrizia Vici, Luciano Mariani, and Aldo Venuti
    European Journal of Cancer (2016) 58 :52
  • Targeting the Epidermal Growth Factor Receptor in Epithelial Ovarian Cancer: Current Knowledge and Future Challenges
    Doris R. Siwak, Mark Carey, Bryan T. Hennessy, Catherine T. Nguyen, Mollianne J. McGahren Murray, Laura Nolden, and Gordon B. Mills
    Journal of Oncology (2010) 2010 :1
  • The Src Family Kinase Yes Triggers Hyperosmotic Activation of the Epidermal Growth Factor Receptor and CD95
    Roland Reinehr, Stephan Becker, Andrea Höngen, and Dieter Haüssinger
    Journal of Biological Chemistry (2004) 279 :23977
  • Molecular Mechanisms of Na/K-ATPase-Mediated Signal Transduction
    Annals of the New York Academy of Sciences (2003) 986 :497
  • Salivary Duct Carcinoma of the Parotid Gland: Is Adjuvant HER-2–Targeted Therapy Required?
    Jong Sil Lee, Oh Jin Kwon, Jung Je Park, and Ji Hyun Seo
    Journal of Oral and Maxillofacial Surgery (2014) 72 :1023
  • Src-mediated RGS16 Tyrosine Phosphorylation Promotes RGS16 Stability
    Alexandrine Derrien, Bin Zheng, James L. Osterhout, Yong-Chao Ma, Graeme Milligan, Marilyn G. Farquhar, and Kirk M. Druey
    Journal of Biological Chemistry (2003) 278 :16107
  • AngiotensinII mediates cardiomyocyte hypertrophic growth pathways via MMP-dependent HB-EGF liberation
    Nicola J. Smith, Ross D. Hannan, Walter G. Thomas, and Rebecca A. Lew
    Letters in Peptide Science (2003) 10 :431
  • Berberine targets epidermal growth factor receptor signaling to suppress prostate cancer proliferation in vitro
    Molecular Medicine Reports (2015) 11 :2125
  • Mesenchymal miR-21 regulates branching morphogenesis in murine submandibular gland in vitro
    Toru Hayashi, Noriko Koyama, Yukio Azuma, and Masanori Kashimata
    Developmental Biology (2011) 352 :299
  • The oncogene HER2: its signaling and transforming functions and its role in human cancer pathogenesis
    M M Moasser
    Oncogene (2007) 26 :6469
  • Activation of the EGF Receptor by Ligand Binding and Oncogenic Mutations: The “Rotation Model”
    Endang Purba, Ei-ichiro Saita, and Ichiro Maruyama
    Cells (2017) 6 :13
  • Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors
    Melodie Thomas
    Cancer Nursing (2003) 26 :21S???25S
  • Serum epidermal growth factor receptor/HER-2 predicts poor survival in patients with metastatic breast cancer
    Christopher Souder, Kim Leitzel, Suhail M. Ali, Laurence Demers, Dean B. Evans, Hilary A. Chaudri-Ross, Wolfgang Hackl, Peter Hamer, Walter Carney, and Allan Lipton
    Cancer (2006) 107 :2337
  • Novel Role for Amphiregulin in Protection from Liver Injury
    Carmen Berasain, Elena R. García-Trevijano, Josefa Castillo, Elena Erroba, Mónica Santamaría, David C. Lee, Jesús Prieto, and Matías A. Avila
    Journal of Biological Chemistry (2005) 280 :19012
  • Novel [99mTcN]2+ Labeled EGFR Inhibitors as Potential Radiotracers for Single Photon Emission Computed Tomography (SPECT) Tumor Imaging
    Mingxia Zhao, Hongyu Ning, Man Feng, Shilei Li, Jin Chang, and Chuanmin Qi
    Molecules (2014) 19 :5508
  • Oxytocin receptor elicits different EGFR/MAPK activation patterns depending on its localization in caveolin-1 enriched domains
    Valeria Rimoldi, Alessandra Reversi, Elena Taverna, Patrizia Rosa, Maura Francolini, Paola Cassoni, Marco Parenti, and Bice Chini
    Oncogene (2003) 22 :6054
  • EGFR Inhibitor Enhances Cisplatin Sensitivity of Oral Squamous Cell Carcinoma Cell Lines
    Yukihiro Hiraishi, Takeshi Wada, Ken Nakatani, Itaru Tojyo, Takashi Matsumoto, Norifumi Kiga, Kenji Negoro, and Shigeyuki Fujita
    Pathology & Oncology Research (2008) 14 :39
  • Serenoa repens, selenium and lycopene to manage lower urinary tract symptoms suggestive for benign prostatic hyperplasia
    Andrea Russo, Paolo Capogrosso, Giovanni La Croce, Eugenio Ventimiglia, Luca Boeri, Alberto Briganti, Rocco Damiano, Francesco Montorsi, and Andrea Salonia
    Expert Opinion on Drug Safety (2016) 15 :1661
  • EGFR-dependent ERK activation triggers hydrogen peroxide-induced apoptosis in OK renal epithelial cells
    Ju Suk Lee, Su Yung Kim, Chae Hwa Kwon, and Yong Keun Kim
    Archives of Toxicology (2006) 80 :337
  • Loss of PTEN/MMAC1/TEP in EGF receptor-expressing tumor cells counteracts the antitumor action of EGFR tyrosine kinase inhibitors
    Roberto Bianco, Incheol Shin, Christoph A Ritter, F Michael Yakes, Andrea Basso, Neal Rosen, Junji Tsurutani, Phillip A Dennis, Gordon B Mills, and Carlos L Arteaga
    Oncogene (2003) 22 :2812
  • Electrostatic interactions of peptides flanking the tyrosine kinase domain in the epidermal growth factor receptor provides a model for intracellular dimerization and autophosphorylation
    Sami Aifa, Nabil Miled, Fakher Frikha, Mohamed R. Aniba, Samuel P.S. Svensson, and Ahmed Rebai
    Proteins: Structure, Function, and Bioinformatics (2005) 62 :1036
  • Host gene targets for novel influenza therapies elucidated by high-throughput RNA interference screens
    Victoria A. Meliopoulos, Lauren E. Andersen, Katherine F. Birrer, Kaylene J. Simpson, John W. Lowenthal, Andrew G. D. Bean, John Stambas, Cameron R. Stewart, S. Mark Tompkins, Victor W. van Beusechem, Iain Fraser, Musa Mhlanga, Samantha Barichievy, Queta Smith, Devin Leake, Jon Karpilow, Amy Buck, Ghil Jona, and Ralph A. Tripp
    The FASEB Journal (2012) 26 :1372
  • Ergosta-7,22-diene-2β,3α,9α-triol (EGDT) from Ganoderma lucidum inhibits nasopharyngeal carcinoma cells by blocking EGFR signaling pathway
    Wen-Wei Wu, Zi-Jing Ye, Yi-Mou Xu, Jin Zhang, and Jin-Sen Tang
    Chinese Herbal Medicines (2018) 10 :27
  • Expression of the HER1–4 family of receptor tyrosine kinases in breast cancer
    Caroline J Witton, Jonathan R Reeves, James J Going, Timothy G Cooke, and John MS Bartlett
    The Journal of Pathology (2003) 200 :290
  • Molecular mechanisms underlying IGF-I-induced attenuation of the growth-inhibitory activity of trastuzumab (Herceptin) on SKBR3 breast cancer cells
    Yuhong Lu, Xiaolin Zi, and Michael Pollak
    International Journal of Cancer (2004) 108 :334
  • P2Y2 nucleotide receptor activation enhances the aggregation and self-organization of dispersed salivary epithelial cells
    Farid G. El-Sayed, Jean M. Camden, Lucas T. Woods, Mahmoud G. Khalafalla, Michael J. Petris, Laurie Erb, and Gary A. Weisman
    American Journal of Physiology-Cell Physiology (2014) 307 :C83
  • Antikörpertherapie in klinischer und präklinischer Anwendung bei gastrointestinalen Karzinomen
    A. Thalheimer, S. Braendlein, P. Vollmers, A. Thiede, D. Meyer, and B. Illert
    Der Onkologe (2007) 13 :236
  • Anti-HER3 Monoclonal Antibody Inhibits Acquired Trastuzumab-Resistant Gynecologic Cancers
    Xinying Li, Yanting Duan, Chunxia Qiao, Tingting Zhou, Ming Yu, Jing Geng, Jiannan Feng, Beifen Shen, Ming Lv, and Yan Li
    Technology in Cancer Research & Treatment (2016) 15 :573
  • Epidermal Growth Factor and Transforming Growth Factor α Mimic the Effects of Insulin in Human Fat Cells and Augment Downstream Signaling in Insulin Resistance
    Silvia Gogg and Ulf Smith
    Journal of Biological Chemistry (2002) 277 :36045
  • Antitumor activity of a novel EGFR tyrosine kinase inhibitor against human lung carcinoma in vitro and in vivo
    Xishan Xiong, Lili Fu, Li Wang, Houan Cai, Lin Li, Hualiang Jiang, Wenhu Duan, and Changlin Mei
    Investigational New Drugs (2009) 27 :1
  • New molecular targets for hepatocellular carcinoma: the ErbB1 signaling system
    Carmen Berasain, Josefa Castillo, Jesús Prieto, and Matías A. Avila
    Liver International (2007) 27 :174
  • Effects of pharmacologic antagonists of epidermal growth factor receptor, PI3K and MEK signal kinases on NF-?B and AP-1 activation and IL-8 and VEGF expression in human head and neck squamous cell carcinoma lines
    Caren C. Bancroft, Zhong Chen, Jason Yeh, John B. Sunwoo, Ning T. Yeh, Sadhana Jackson, Chad Jackson, and Carter Van Waes
    International Journal of Cancer (2002) 99 :538
  • Cetuximab, a Monoclonal Antibody Targeting the Epidermal Growth Factor Receptor, in Combination With Gemcitabine for Advanced Pancreatic Cancer: A Multicenter Phase II Trial
    Henry Q. Xiong, Arthur Rosenberg, Albert LoBuglio, William Schmidt, Robert A. Wolff, John Deutsch, Michael Needle, and James L. Abbruzzese
    Journal of Clinical Oncology (2004) 22 :2610
  • Syntheses of 4-(indole-3-yl)quinazolines – A new class of epidermal growth factor receptor tyrosine kinase inhibitors
    Anja Lüth and Werner Löwe
    European Journal of Medicinal Chemistry (2008) 43 :1478
  • EGFR inhibition in the treatment of non-small cell lung cancer
    David E. Gerber
    Drug Development Research (2008) 69 :359
  • YL143, a novel mutant selective irreversible EGFR inhibitor, overcomes EGFRL858R, T790M -mutant resistance in vitro and in vivo
    Zhang Zhang, Jian Zou, Lei Yu, Jinfeng Luo, Yan Li, Zhengchao Tu, Xiaomei Ren, Hongcheng Wei, Liyan Song, Xiaoyun Lu, and Ke Ding
    Cancer Medicine (2018) 7 :1430
  • Targeting mitogen-activated protein kinase kinase with the inhibitor PD0325901 decreases hepatocellular carcinoma growth in vitro and in mouse model systems
    Matthew Hennig, Michele T. Yip-Schneider, Sabrina Wentz, Huangbing Wu, S. K. Hekmatyar, Patrick Klein, Navin Bansal, and C. Max Schmidt
    Hepatology (2010) 51 :1218
  • Dasatinib sensitizes KRAS mutant colorectal tumors to cetuximab
    E F Dunn, M Iida, R A Myers, D A Campbell, K A Hintz, E A Armstrong, C Li, and D L Wheeler
    Oncogene (2011) 30 :561
  • Understanding EGFR Signaling in Breast Cancer and Breast Cancer Stem Cells: Overexpression and Therapeutic Implications
    Ibrahim O Alanazi and Zahid Khan
    Asian Pacific Journal of Cancer Prevention (2016) 17 :445
  • Predicting response to epidermal growth factor receptor-targeted therapy in colorectal cancer
    Richard Adams and Tim Maughan
    Expert Review of Anticancer Therapy (2007) 7 :503
  • Identification of the epidermal growth factor receptor as the receptor for Salmonella Rck–dependent invasion
    Agnès Wiedemann, Lily Mijouin, Mohammed Akli Ayoub, Emilie Barilleau, Sylvie Canepa, Ana Paula Teixeira-Gomes, Yves Le Vern, Manon Rosselin, Eric Reiter, and Philippe Velge
    The FASEB Journal (2016) 30 :4180
  • A putative molecular-activation switch in the transmembrane domain of erbB2
    S. J. Fleishman, J. Schlessinger, and N. Ben-Tal
    Proceedings of the National Academy of Sciences (2002) 99 :15937
  • No association between epidermal growth factor and epidermal growth factor receptor polymorphisms and nasopharyngeal carcinoma
    Lin-Bo Gao, Ye-Sheng Wei, Bin Zhou, Yan-Yun Wang, Wei-Bo Liang, Cui Li, Yi Li, Peng Bai, Wen-Liang Fang, Hui Xue, and Lin Zhang
    Cancer Genetics and Cytogenetics (2008) 185 :69
  • The Membrane-Lytic Peptides K8L9 and Melittin Enter Cancer Cells via Receptor Endocytosis following Subcytotoxic Exposure
    Masayuki Kohno, Tomohisa Horibe, Koji Ohara, Shinji Ito, and Koji Kawakami
    Chemistry & Biology (2014) 21 :1522
  • Receptor Type Protein Tyrosine Phosphatase-Kappa Mediates Cross-Talk between Transforming Growth Factor-Beta and Epidermal Growth Factor Receptor Signaling Pathways in Human Keratinocytes
    Yiru Xu, Dustin Baker, TaiHao Quan, Joseph J. Baldassare, John J. Voorhees, Gary J. Fisher, and Jonathan Chernoff
    Molecular Biology of the Cell (2010) 21 :29
  • MiR-25-3p attenuates the proliferation of tongue squamous cell carcinoma cell line Tca8113
    Jia-Ying Xu, Li-Li Yang, Chao Ma, Yuan-Liang Huang, Gui-Xiang Zhu, and Qi-Lin Chen
    Asian Pacific Journal of Tropical Medicine (2013) 6 :743
  • COX-2/EGFR expression and survival among women with adenocarcinoma of the lung
    A. L. Van Dyke, M. L. Cote, G. M. Prysak, G. B. Claeys, A. S. Wenzlaff, V. C. Murphy, F. Lonardo, and A. G. Schwartz
    Carcinogenesis (2008) 29 :1781
  • Tumor necrosis factor-α-stimulated membrane type 1-matrix metalloproteinase production is modulated by epidermal growth factor receptor signaling in human gingival fibroblasts
    P. C. Smith, J. Guerrero, N. Tobar, M. Cáceres, M. J. González, and J. Martínez
    Journal of Periodontal Research (2009) 44 :73
  • Cetuximab-resistant oral squamous cell carcinoma cells become sensitive in anchorage-independent culture conditions through activation of the EGFR/AKT pathway
    Yuichi OHNISHI, Hiroki YASUI, Kenji KAKUDO, and Masami NOZAKI
    Japanese Journal of Oral and Maxillofacial Surgery (2016) 62 :476
  • Human epidermal growth factor receptor 2 status of gastric cancer patients in Asia: results from a large, multicountry study
    Nirmala Pathmanathan, Jing-shu Geng, Wencai Li, Xiu Nie, Januario Veloso, John Wang, Julie Hill, Philip Mccloud, and Michael Bilous
    Asia-Pacific Journal of Clinical Oncology (2017) 13 :249
  • Gene expression and immunolocalization of heparin-binding epidermal growth factor-like growth factor and human epidermal growth factor receptors in human corpus luteum
    Yuki Akayama, Shigeki Takekida, Noriyuki Ohara, Hisashi Tateiwa, Wei Chen, Koji Nakabayashi, and Takeshi Maruo
    Human Reproduction (2005) 20 :2708
  • Production of Specific Anti-EGFR Single Chain Antibodies: A Promising Strategy in the Immunotherapy of EGFR Expressing Tumor Tissues
    S. Saeed Mohammadi, Farideh Hosseinzadeh, and Foroogh Nejatollahi
    Iranian Journal of Cancer Prevention (2017) In Press :
  • Molecular Pathology of Lung Cancer: Current Status and Future Directions
    Mee Sook Roh
    Tuberculosis and Respiratory Diseases (2014) 77 :49
  • Wounding Induces Motility in Sheets of Corneal Epithelial Cells through Loss of Spatial Constraints
    Ethan R. Block, Abigail R. Matela, Nirmala SundarRaj, Erik R. Iszkula, and Jes K. Klarlund
    Journal of Biological Chemistry (2004) 279 :24307
  • The Protein Tyrosine Phosphatase TCPTP Suppresses the Tumorigenicity of Glioblastoma Cells Expressing a Mutant Epidermal Growth Factor Receptor
    Manuela Klingler-Hoffmann, Michelle T. Fodero-Tavoletti, Kazuhiko Mishima, Yoshitaka Narita, Webster K. Cavenee, Frank B. Furnari, H.-J. Su Huang, and Tony Tiganis
    Journal of Biological Chemistry (2001) 276 :46313
  • Gangliosides Inhibit Urokinase-Type Plasminogen Activator (uPA)-Dependent Squamous Carcinoma Cell Migration by Preventing uPA Receptor/α5β1 Integrin/Epidermal Growth Factor Receptor Interactions
    Xiao-Qi Wang, Ping Sun, and Amy S. Paller
    Journal of Investigative Dermatology (2005) 124 :839
  • Beyond Herceptin and Gleevec
    Oliver M Fischer, Sylvia Streit, Stefan Hart, and Axel Ullrich
    Current Opinion in Chemical Biology (2003) 7 :490
  • Mechanism of action of potato carboxypeptidase inhibitor (PCI) as an EGF blocker
    Marta Sitjà-Arnau, Miguel A. Molina, Carmen Blanco-Aparicio, Laura Ferrer-Soler, Julia Lorenzo, Francesc X. Avilés, Enrique Querol, and Rafael de Llorens
    Cancer Letters (2005) 226 :169
  • Thrombin mediates mitogenesis and survival of human endothelial cells through distinct mechanisms
    Panagiota Zania, Matthew Papaconstantinou, Christodoulos S. Flordellis, Michael E. Maragoudakis, and Nikos E. Tsopanoglou
    American Journal of Physiology-Cell Physiology (2008) 294 :C1215
  • Differential responses by pancreatic carcinoma cell lines to prolonged exposure to Erbitux (IMC-C225) anti-EGFR antibody
    Zhi-qiang Huang, Donald J Buchsbaum, Kevin P Raisch, James A Bonner, Kirby I Bland, and Selwyn M Vickers
    Journal of Surgical Research (2003) 111 :274
  • EGFR gene and protein expression in breast cancers
    K. Park, S. Han, E. Shin, H.J. Kim, and J.Y. Kim
    European Journal of Surgical Oncology (EJSO) (2007) 33 :956
  • Functions of epidermal growth factor receptor in cisplatin response of thyroid cells
    Antonella Muscella, Loredana Urso, Nadia Calabriso, Carla Vetrugno, Francesco Paolo Fanizzi, Carlo Storelli, and Santo Marsigliante
    Biochemical Pharmacology (2009) 77 :979
  • Requirement of the epidermal growth factor receptor in renal epithelial cell proliferation and migration
    Shougang Zhuang, Yujing Dang, and Rick G. Schnellmann
    American Journal of Physiology-Renal Physiology (2004) 287 :F365
  • Inhibitors of Epidermoid Growth Factor Receptor Suppress Cell Growth and Enhance Chemosensitivity of Nasopharyngeal Cancer Cells in vitro
    Chih-Hung Hsu, Ming Gao, Chi-Long Chen, Pei-Yen Yeh, and Ann-Lii Cheng
    Oncology (2005) 68 :538
  • Insulino-mimetic and anti-diabetic effects of zinc
    George Vardatsikos, Nihar R. Pandey, and Ashok K. Srivastava
    Journal of Inorganic Biochemistry (2013) 120 :8
  • STAT3-mediated Coincidence Detection Regulates Noncanonical Immediate Early Gene Induction
    Matthew S. Waitkus, Unni M. Chandrasekharan, Belinda Willard, S. Jaharul Haque, and Paul E. DiCorleto
    Journal of Biological Chemistry (2013) 288 :11988
  • Mitochondrial potassium transport: the role of the mitochondrial ATP-sensitive K+ channel in cardiac function and cardioprotection
    Keith D Garlid, Pierre Dos Santos, Zi-Jian Xie, Alexandre D.T Costa, and Petr Paucek
    Biochimica et Biophysica Acta (BBA) - Bioenergetics (2003) 1606 :1
  • Epidermal growth factor receptor and proliferating cell nuclear antigen expression in urine ThinPrep specimens
    E. N. Politi, A. C. Lazaris, S. Lambropoulou, D. Alexopoulou, V. Kyriakidou, and H. Koutselini
    Cytopathology (2005) 16 :303
    Narendra Nathoo, Samuel Goldlust, and Michael A. Vogelbaum
    Neurosurgery (2004) 54 :1480
  • Ultraviolet (UV) light irradiation induced signal transduction in skin photoaging
    Yiru Xu and Gary J. Fisher
    Journal of Dermatological Science Supplement (2005) 1 :S1
  • Placental gene expression patterns of epidermal growth factor in intrauterine growth restriction
    Attila Rab, Imre Szentpéteri, László Kornya, Balázs Börzsönyi, Csaba Demendi, and József Gábor Joó
    European Journal of Obstetrics & Gynecology and Reproductive Biology (2013) 170 :96
  • Elastase-released Epidermal Growth Factor Recruits Epidermal Growth Factor Receptor and Extracellular Signal-regulated Kinases to Down-regulate Tropoelastin mRNA in Lung Fibroblasts
    Sandra J. DiCamillo, Isabel Carreras, Maria V. Panchenko, Phillip J. Stone, Matthew A. Nugent, Judith A. Foster, and Mikhail P. Panchenko
    Journal of Biological Chemistry (2002) 277 :18938
  • Cyclooxygenase-2 transactivates the epidermal growth factor receptor through specific E-prostanoid receptors and Tumor Necrosis Factor-α converting enzyme
    Mazin A. Al-Salihi, Scott C. Ulmer, Thao Doan, Cory D. Nelson, Tracy Crotty, Stephen M. Prescott, Diana M. Stafforini, and Matthew K. Topham
    Cellular Signalling (2007) 19 :1956
  • MicroRNAs: novel biomarkers for lung cancer diagnosis, prediction and treatment
    Qiming Wang, Sheng Wang, Huijuan Wang, Peng Li, and Zhiyong Ma
    Experimental Biology and Medicine (2012) 237 :227
  • Rationale for the epidermal growth factor receptor as a target for cancer therapy
    Laura S. Wood
    Seminars in Oncology Nursing (2002) 18 :3
  • Differential Efficacy of Combined Therapy With Radiation and AEE788 in High and Low EGFR-Expressing Androgen-Independent Prostate Tumor Models
    Jessica Huamani, Christopher Willey, Dinesh Thotala, Kenneth J. Niermann, Michelle Reyzer, Lauren Leavitt, Cameron Jones, Arthur Fleishcher, Richard Caprioli, Dennis E. Hallahan, and Dong Wook Nathan Kim
    International Journal of Radiation Oncology*Biology*Physics (2008) 71 :237
  • Oxidized LDL and 4-hydroxynonenal modulate tyrosine kinase receptor activity
    Anne Negre-Salvayre, Otilia Vieira, Isabelle Escargueil-Blanc, and Robert Salvayre
    Molecular Aspects of Medicine (2003) 24 :251
  • Overexpression of ErbB2 receptor inhibits IGF-I-induced Shc–MAPK signaling pathway in breast cancer cells
    Yuhong Lu, Xiaolin Zi, Yunhua Zhao, and Michael Pollak
    Biochemical and Biophysical Research Communications (2004) 313 :709
  • Growth hormone-releasing hormone antagonists abolish the transactivation of human epidermal growth factor receptors in advanced prostate cancer models
    Laura Muñoz-Moreno, M. Isabel Arenas, M. José Carmena, Andrew V. Schally, Juan C. Prieto, and Ana M. Bajo
    Investigational New Drugs (2014) 32 :871
  • Association analysis of polymorphisms in EGFR , HER2 , ESR1 and THRA genes with coronary artery diseases
    Maha Rebaї, Imen Kallel, Rania Abdelhedi, Najla kharrat, Nouha Abdemoula Bouayed, Leila Abid, and Ahmed Rebaї
    Egyptian Journal of Medical Human Genetics (2017) 18 :241
  • Epidermal Growth Factor Receptor as a Target to Improve Treatment of Lung Cancer
    Nicolaus H. Andratschke, Klaus H. Dittmann, Kathryn A. Mason, Zhen Fan, Zhongxing Liao, Ritsuko Komaki, K.Kian Ang, and Luka Milas
    Clinical Lung Cancer (2004) 5 :340
  • Mechanical stress-initiated signal transduction in vascular smooth muscle cells in vitro and in vivo
    Chaohong Li and Qingbo Xu
    Cellular Signalling (2007) 19 :881
  • Phosphorylated EGFR and PI3K/Akt signaling kinases are expressed in circulating tumor cells of breast cancer patients
    Galatea Kallergi, Sofia Agelaki, Antonia Kalykaki, Christos Stournaras, Dimitris Mavroudis, and Vassilis Georgoulias
    Breast Cancer Research (2008) 10 :
  • Overexpression of human β-defensin-3 in oral dysplasia: Potential role in macrophage trafficking
    Hameem I. Kawsar, Aaron Weinberg, Stanley A. Hirsch, Andrea Venizelos, Scott Howell, Bin Jiang, and Ge Jin
    Oral Oncology (2009) 45 :696
  • Inhibition of Epidermal Growth Factor Receptor and PI3K/Akt Signaling Suppresses Cell Proliferation and Survival through Regulation of Stat3 Activation in Human Cutaneous Squamous Cell Carcinoma
    Toshinori Bito, Nahoko Sumita, Masashi Ashida, Arief Budiyanto, Masato Ueda, Masamitsu Ichihashi, Yoshiki Tokura, and Chikako Nishigori
    Journal of Skin Cancer (2011) 2011 :1
  • Plasma Membrane Phospholipid Scramblase 1 Promotes EGF-dependent Activation of c-Src through the Epidermal Growth Factor Receptor
    Meera Nanjundan, Jun Sun, Ji Zhao, Quansheng Zhou, Peter J. Sims, and Therese Wiedmer
    Journal of Biological Chemistry (2003) 278 :37413
  • Apple procyanidins affect several members of the ErbB receptor tyrosine kinase family in vitro
    Nicole Teller, Matthias Roth, Melanie Esselen, Diana Fridrich, Ute Boettler, Volker Blust, Frank Will, Helmut Dietrich, Francis Raul, Wolfgang Hümmer, Elke Richling, Peter Schreier, and Doris Marko
    Food & Function (2013) 4 :689
  • A simple procedure for the derivation of electron density based surfaces of drug-receptor complexes from a combination of X-ray data and theoretical calculations
    Stefan Mebs, Anja Lüth, and Peter Luger
    Bioorganic & Medicinal Chemistry (2010) 18 :5965
  • Targeting the Epidermal Growth Factor Receptor in Colorectal Cancer: Advances and Controversies
    Antoine Italiano
    Oncology (2006) 70 :161
  • Molecular Alterations Associated with the NMDA Preconditioning-Induced Neuroprotective Mechanism Against Glutamate Cytotoxicity
    Shlomo Sragovich, Yael Bromberg, Oded Sperling, and Esther Zoref-Shani
    Journal of Molecular Neuroscience (2012) 47 :519
  • Role for the epidermal growth factor receptor in neurofibromatosis-related peripheral nerve tumorigenesis
    Benjamin C. Ling, Jianqiang Wu, Shyra J. Miller, Kelly R. Monk, Rania Shamekh, Tilat A. Rizvi, Gabrielle DeCourten-Myers, Kristine S. Vogel, Jeffrey E. DeClue, and Nancy Ratner
    Cancer Cell (2005) 7 :65
  • Gold nanoparticle-conjugated quercetin inhibits epithelial-mesenchymal transition, angiogenesis and invasivenessviaEGFR/VEGFR-2-mediated pathway in breast cancer
    S. Balakrishnan, F. A. Bhat, P. Raja Singh, S. Mukherjee, P. Elumalai, S. Das, C. R. Patra, and J. Arunakaran
    Cell Proliferation (2016) 49 :678
  • GPCR-induced migration of breast carcinoma cells depends on both EGFR signal transactivation and EGFR-independent pathways
    Stefan Hart, Oliver M. Fischer, Norbert Prenzel, Esther Zwick-Wallasch, Matthias Schneider, Lothar Hennighausen, and Axel Ullrich
    Biological Chemistry (2005) 386 :
  • EGF-R regulates MMP function in fibroblasts through MAPK and AP-1 pathways
    Risto Kajanne, Päivi Miettinen, Annika Mehlem, Suvi-Katri Leivonen, Michael Birrer, Marco Foschi, Veli-Matti Kähäri, and Sirpa Leppä
    Journal of Cellular Physiology (2007) 212 :489
  • Negative Regulation of HER2 Signaling by the PEST-type Protein-tyrosine Phosphatase BDP1
    Miriam Gensler, Marcus Buschbeck, and Axel Ullrich
    Journal of Biological Chemistry (2004) 279 :12110
  • Astrocytic transactivation by α2A-adrenergic and 5-HT2B serotonergic signaling
    Liang Peng, Baoman Li, Ting Du, Ebenezer K.C. Kong, Xiaoling Hu, Shiquen Zhang, Xiaolei Shan, and Meixia Zhang
    Neurochemistry International (2010) 57 :421
  • Expression of the epidermal growth factor receptor family in normal and malignant urothelium
    Ranveig Rotterud, Jahn Marthin Nesland, Aasmund Berner, and Sophie D. Fossa
    BJU International (2005) 95 :1344
  • Analysis of EGFR signaling pathway in nasopharyngeal carcinoma cells by quantitative phosphoproteomics
    Lin Ruan, Xin-Hui Li, Xun-Xun Wan, Hong Yi, Cui Li, Mao-Yu Li, Peng-Fei Zhang, Gu-Qing Zeng, Jia-Quan Qu, Qiu-Yan He, Jian-Huang Li, Yu Chen, Zhu-Chu Chen, and Zhi-Qiang Xiao
    Proteome Science (2011) 9 :35
  • G Protein–Coupled Receptors Provide Survival Signals in Prostate Cancer
    Charles W. Yowell and Yehia Daaka
    Clinical Prostate Cancer (2002) 1 :177
  • ADAM-mediated amphiregulin shedding and EGFR transactivation
    S. Kasina, P. A. Scherle, C. L. Hall, and J. A. Macoska
    Cell Proliferation (2009) 42 :799
  • Prepubertal genistein exposure affects erbB2/Akt signal and reduces rat mammary tumorigenesis
    Jun-Hua Peng, Jun-Dong Zhu, Man-Tian Mi, Fu-Jun Li, Lin Cai, Ju-Zi Dong, Hua-Xin Zhang, Yong Zhao, and Rong-Li Xue
    European Journal of Cancer Prevention (2010) 19 :110
  • Role and regulation of EGFR in actin remodeling in sperm capacitation and the acrosome reaction
    Haim Breitbart and Nir Etkovitz
    Asian Journal of Andrology (2011) 13 :106
  • AngiotensinII mediates cardiomyocyte hypertrophic growth pathways via MMP-dependent HB-EGF liberation
    Nicola J. Smith, Ross D. Hannan, Walter G. Thomas, and Rebecca A. Lew
    International Journal of Peptide Research and Therapeutics (2003) 10 :431
  • Naphthofuroquinone derivatives: Inhibition of receptor tyrosine kinases
    Kee-In Lee, Youmie Park, Su-Jin Park, Jung-Hwan Hwang, Sung-Jin Lee, Gun-Do Kim, Woo-Kyu Park, Sunghou Lee, Daeyoung Jeong, Jae-Yang Kong, Hee-Kyoung Kang, and Heeyeong Cho
    Bioorganic & Medicinal Chemistry Letters (2006) 16 :737
  • Anti-tumor activity of a novel EGFR tyrosine kinase inhibitor against human NSCLC in vitro and in vivo
    Jing Li, Yan Li, Zhi-qiang Feng, and Xiao-guang Chen
    Cancer Letters (2009) 279 :213
  • Depolarization-induced, glutamate receptor–mediated, and transactivation-dependent extracellular-signal regulated kinase phosphorylation in cultured cerebellar granule neurons
    L. Gu, B. Li, X. Yang, X. Hu, X. Huang, L. Hertz, and L. Peng
    Neuroscience (2007) 147 :342
  • ErbB4 Expression and Mutation in Japanese Patients with Lung Cancer
    Hidefumi Sasaki, Katsuhiro Okuda, Osamu Kawano, Katsuhiko Endo, Haruhiro Yukiue, Tomoki Yokoyama, Motoki Yano, and Yoshitaka Fujii
    Clinical Lung Cancer (2007) 8 :429
  • EGF receptor transactivation by urokinase receptor stimulus through a mechanism involving Src and matrix metalloproteinases
    Javier Guerrero, Juan Francisco Santibañez, Alfonso González, and Jorge Martı́nez
    Experimental Cell Research (2004) 292 :201
  • Her-2/neu and EGFR tyrosine kinase activation predict the efficacy of trastuzumab-based therapy in patients with metastatic breast cancer
    Gernot Hudelist, Wolfgang J. Köstler, Klaus Czerwenka, Ernst Kubista, Johannes Attems, Ruth Müller, Daphne Gschwantler-Kaulich, Mahmood Manavi, Isabell Huber, Heinz Hoschützky, Christoph C. Zielinski, and Christian F. Singer
    International Journal of Cancer (2006) 118 :1126
  • Erlotinib: success of a molecularly targeted agent for the treatment of advanced pancreatic cancer
    Stephen A Welch and Malcolm J Moore
    Future Oncology (2007) 3 :247
  • Computational cell fate modelling for discovery of rewiring in apoptotic network for enhanced cancer drug sensitivity
    Shital K Mishra, Sourav S Bhowmick, Huey Chua, Fan Zhang, and Jie Zheng
    BMC Systems Biology (2015) 9 :S4
  • Activation of epidermal growth factor receptor causes astrocytes to form cribriform structures
    Bin Liu and Arthur H. Neufeld
    Glia (2004) 46 :153
  • Epidermal Growth Factor Receptor Regulates MT1-MMP and MMP-2 Synthesis in SiHa Cells via Both PI3-K/AKT and MAPK/ERK Pathways
    Zongfeng Zhang, Tiefang Song, Yinglan Jin, Jiaqi Pan, Liying Zhang, Lingdi Wang, and Peiling Li
    International Journal of Gynecological Cancer (2009) 19 :998
  • Mechanisms of HER2-Induced Endothelial Cell Retraction
    W. Bradford Carter, Guilian Niu, Michael D. Ward, Gregory Small, Julianne E. Hahn, and Barbara J. Muffly
    Annals of Surgical Oncology (2007) 14 :2971
  • Gene expression profiles of NO- and HNO-donor treated breast cancer cells: insights into tumor response and resistance pathways
    Robert Y.S. Cheng, Debashree Basudhar, Lisa A. Ridnour, Julie L. Heinecke, Aparna H. Kesarwala, Sharon Glynn, Christopher H. Switzer, Stefan Ambs, Katrina M. Miranda, and David A. Wink
    Nitric Oxide (2014) 43 :17
  • ErbB Receptors as Prognostic and Therapeutic Drug Targets in Bone and Soft Tissue Sarcomas
    Hongsheng Wang, Qingbo Yang, Zeze Fu, Dongqing Zuo, Yingqi Hua, and Zhengdong Cai
    Cancer Investigation (2014) 32 :533
  • EGFR expression is linked to osteopontin and Nf-κB signaling in clear cell renal cell carcinoma
    K. Matušan-Ilijaš, G. Damante, D. Fabbro, G. Đorđević, I. Hadžisejdić, M. Grahovac, M. Avirović, B. Grahovac, N. Jonjić, and K. Lučin
    Clinical and Translational Oncology (2013) 15 :65
  • Reproducibility of the EGFR immunohistochemistry scores for tumor samples from patients with advanced non-small cell lung cancer
    Alejandro Avilés-Salas, Saé Muñiz-Hernández, Héctor Aquiles Maldonado-Martínez, José G. Chanona-Vilchis, Laura-Alejandra Ramírez-Tirado, Norma HernáNdez-Pedro, Rita Dorantes-Heredia, José Manuel RuíZ-Morales, Daniel Motola-Kuba, and Oscar Arrieta
    Oncology Letters (2017) 13 :912
  • EGFR induces expression of IRF-1viaSTAT1 and STAT3 activation leading to growth arrest of human cancer cells
    Peter Andersen, Mikkel Wandahl Pedersen, Anders Woetmann, Mette Villingshøj, Marie-Thérése Stockhausen, Niels Ødum, and Hans Skovgaard Poulsen
    International Journal of Cancer (2008) 122 :342
  • Fluoxetine-mediated 5-HT2B receptor stimulation in astrocytes causes EGF receptor transactivation and ERK phosphorylation
    Baoman Li, Shiquen Zhang, Hongyan Zhang, Weiwei Nu, Liping Cai, Leif Hertz, and Liang Peng
    Psychopharmacology (2008) 201 :443
  • EGFR-dependent signalling reduced and p38 dependent apoptosis required by Gallic acid in Malignant Mesothelioma cells
    Asuman Demiroglu-Zergeroglu, Gulsife Candemir, Ebru Turhanlar, Fatma Sagir, and Nurettin Ayvali
    Biomedicine & Pharmacotherapy (2016) 84 :2000
  • Activation of the Epidermal Growth Factor Receptor (EGFR) by a Novel Metalloprotease Pathway
    David A. Bergin, Catherine M. Greene, Erwin E. Sterchi, Cliona Kenna, Patrick Geraghty, Abderazzaq Belaaouaj, Clifford C. Taggart, Shane J. O'Neill, and Noel G. McElvaney
    Journal of Biological Chemistry (2008) 283 :31736
  • Motility Enhancement by Tumor-Derived Mutant E-Cadherin Is Sensitive to Treatment with Epidermal Growth Factor Receptor and Phosphatidylinositol 3-Kinase Inhibitors
    Margit Fuchs, Peter Hutzler, Ingrid Brunner, Jürgen Schlegel, Jörg Mages, Ute Reuning, Sandra Hapke, Justus Duyster, Setsuo Hirohashi, Takuya Genda, Michiie Sakamoto, Florian Überall, Heinz Höfler, Karl-Friedrich Becker, and Birgit Luber
    Experimental Cell Research (2002) 276 :129
  • An update on epidermal growth factor receptor inhibitors
    Shanu Modi and Andrew D. Seidman
    Current Oncology Reports (2002) 4 :47
  • Transactivation of ErbB2 and ErbB3 by Tumor Necrosis Factor-α and Anisomycin Leads to Impaired Insulin Signaling through Serine/Threonine Phosphorylation of IRS Proteins
    Rina Hemi, Keren Paz, Nadine Wertheim, Avraham Karasik, Yehiel Zick, and Hannah Kanety
    Journal of Biological Chemistry (2002) 277 :8961
  • Topical N-Acetyl Cysteine and Genistein Prevent Ultraviolet-Light-Induced Signaling That Leads to Photoaging in Human Skin in vivo
    Sewon Kang, Jin Ho Chung, Joo Heung Lee, Gary J. Fisher, Yian Sheng Wan, Elizabeth A. Duell, and John J. Voorhees
    Journal of Investigative Dermatology (2003) 120 :835
  • Development of Precise Pharmocodiagnostic (PharmDx) Tests for Molecular Targeted Therapies
    Yoichi Tani, Yutaka Hatanaka, and Kaoru Hashizume
  • EGFR-targeted immunoliposomes derived from the monoclonal antibody EMD72000 mediate specific and efficient drug delivery to a variety of colorectal cancer cells
    Christoph Mamot, Reto Ritschard, Willy Küng, John W. Park, Richard Herrmann, and Christoph F. Rochlitz
    Journal of Drug Targeting (2006) 14 :215
  • Nicotine-induced phosphorylation of Akt through epidermal growth factor receptor and Src in PC12h cells
    Hitoshi Nakayama, Tadahiro Numakawa, and Toshihiko Ikeuchi
    Journal of Neurochemistry (2002) 83 :1372
  • Extracellular heat shock protein 70 mediates heat stress-induced epidermal growth factor receptor transactivation in A431 carcinoma cells
    Anton L. Evdonin, Irina V. Guzhova, Boris A. Margulis, and Natalia D. Medvedeva
    FEBS Letters (2006) 580 :6674
  • ZD1839 (Gefitinib, ‘Iressa’), an epidermal growth factor receptor-tyrosine kinase inhibitor, enhances the anti-cancer effects of TRAIL in human esophageal squamous cell carcinoma
    Fuminori Teraishi, Shunsuke Kagawa, Takanori Watanabe, Yasuhisa Tango, Takeshi Kawashima, Tatsuo Umeoka, Masahiko Nisizaki, Noriaki Tanaka, and Toshiyoshi Fujiwara
    FEBS Letters (2005) 579 :4069
  • Transactivation of Epidermal Growth Factor Receptor by G Protein-Coupled Receptors: Recent Progress, Challenges and Future Research
    Zhixiang Wang
    International Journal of Molecular Sciences (2016) 17 :95
  • Aberrant expression of proteinase-activated receptor 4 promotes colon cancer cell proliferation through a persistent signaling that involves Src and ErbB-2 kinase
    Valérie Gratio, Francine Walker, Thérèse Lehy, Marc Laburthe, and Dalila Darmoul
    International Journal of Cancer (2009) 124 :1517
  • High-dose atorvastatin ameliorates the uterine microenvironment in streptozotocin-induced diabetic rats
    Burak Zeybek, Mete Ergenoglu, Oytun Erbas, Nuri Yildirim, Ali Akdemir, Altug Yavasoglu, Huseyin Aktug, and Dilek Taskiran
    Gynecological Endocrinology (2014) 30 :789
  • Development of Targeted Therapies in ErbB2-Positive Breast Cancer
    Christian Jackisch, Josef Rüschoff, and Axel Ullrich
    Breast Care (2008) 3 :3
  • Investigating the Function of Three Non-Synonymous SNPs in EGFR Gene: Structural Modelling and Association With Breast Cancer
    Mouna Choura, Fakher Frikha, Najla Kharrat, Sami Aifa, and Ahmed Rebaï
    The Protein Journal (2010) 29 :50
  • Signal transduction and oncogenesis by ErbB/HER receptors
    Mina D Marmor, Kochupurakkal Bose Skaria, and Yosef Yarden
    International Journal of Radiation Oncology*Biology*Physics (2004) 58 :903
  • Involvement of the Src family kinase yes in bile salt-induced apoptosis
    Roland Reinehr, Stephan Becker, Matthias Wettstein, and Dieter Häussinger
    Gastroenterology (2004) 127 :1540
  • Chemokine CXCL16 Expression Suppresses Migration and Invasiveness and Induces Apoptosis in Breast Cancer Cells
    Yeying Fang, Fraser C. Henderson, Qiong Yi, Qianqian Lei, Yan Li, and Nianyong Chen
    Mediators of Inflammation (2014) 2014 :1
  • Wentilactone B from Aspergillus wentii Induces Apoptosis and Inhibits Proliferation and Migration of Human Hepatoma SMMC-7721 Cells
    Zhenwei Zhang, Lei Miao, Weizhang Sun, Binghua Jiao, Bingui Wang, Li Yao, and Caiguo Huang
    Biological and Pharmaceutical Bulletin (2012) 35 :1964
    Gerardo Vázquez-Gómez, Julieta Rubio-Lightbourn, and Jesús Javier Espinosa-Aguirre
    TIP (2016) 19 :54
  • A review of erlotinib and its clinical use
    Patricia A Tang, Ming-Sound Tsao, and Malcolm J Moore
    Expert Opinion on Pharmacotherapy (2006) 7 :177
  • EphA2: expression in the renal medulla and regulation by hypertonicity and urea stress in vitro and in vivo
    Hongshi Xu, Wei Tian, Jessie N. Lindsley, Terry T. Oyama, Juan M. Capasso, Christopher J. Rivard, Herbert T. Cohen, Serena M. Bagnasco, Sharon Anderson, and David M. Cohen
    American Journal of Physiology-Renal Physiology (2005) 288 :F855
  • The Epidermal Growth Factor Receptor (EGFR) Promotes Uptake of Influenza A Viruses (IAV) into Host Cells
    Thorsten Eierhoff, Eike R. Hrincius, Ursula Rescher, Stephan Ludwig, Christina Ehrhardt, and Ron A. M. Fouchier
    PLoS Pathogens (2010) 6 :e1001099
  • Therapeutic and Preventive Effects of an Epidermal Growth Factor Receptor Inhibitor on Oral Squamous Cell Carcinoma
    H Ge, H Liu, Z Fu, and Z Sun
    Journal of International Medical Research (2012) 40 :455
  • The role of HER2, EGFR, and other receptor tyrosine kinases in breast cancer
    Jennifer L. Hsu and Mien-Chie Hung
    Cancer and Metastasis Reviews (2016) 35 :575
  • Gefitinib — a novel targeted approach to treating cancer
    Roy S. Herbst, Masahiro Fukuoka, and José Baselga
    Nature Reviews Cancer (2004) 4 :956
  • R497K polymorphism in epidermal growth factor receptor gene is associated with the risk of acute coronary syndrome
    Lin-Bo Gao, Bin Zhou, Lin Zhang, Ye-Sheng Wei, Yan-Yun Wang, Wei-Bo Liang, Mei-Li Lv, Xin-Min Pan, Yu-Cheng Chen, and Li Rao
    BMC Medical Genetics (2008) 9 :
  • Mechanisms for oncogenic activation of the epidermal growth factor receptor
    Roza Zandi, Alice Bjerregaard Larsen, Peter Andersen, Marie-Thérése Stockhausen, and Hans Skovgaard Poulsen
    Cellular Signalling (2007) 19 :2013
  • A case–control study of the HER2 Ile655Val polymorphism and risk of breast cancer in Taiwan
    Su-Chen Lee, Ming-Feng Hou, Pei-Chen Hsieh, Szu-Hsien Wu, Linda Ann Hou, Hsu Ma, Shin-Meng Tsai, and Li-Yu Tsai
    Clinical Biochemistry (2008) 41 :121
  • Keratinocyte Survival, Differentiation, and Death: Many Roads Lead to Mitogen-Activated Protein Kinase
    Richard L. Eckert, Tatiana Efimova, Shervin R. Dashti, Sivaprakasam Balasubramanian, Anne Deucher, James F. Crish, Michael Sturniolo, and Frederic Bone
    Journal of Investigative Dermatology Symposium Proceedings (2002) 7 :36
  • Cyclooxygenase-2 and prostaglandin signaling in cholangiocarcinoma
    Tong Wu
    Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2005) 1755 :135
  • Protein kinase C α and δ are members of a large kinase family of high potential for novel anticancer targeted therapy
    A. Ghoul, M. Serova, K. A. Benhadji, E. Cvitkovic, S. Faivre, E. Philips, F. Calvo, F. Lokiec, and E. Raymond
    Targeted Oncology (2006) 1 :42
  • Recent advances in the management of non-small cell lung cancer
    Samira Shojaee and Patrick Nana-Sinkam
    F1000Research (2017) 6 :2110
  • Molecular diagnostics for determination of HER2 status in breast cancer
    J.M.S. Bartlett, E. Mallon, and T. Cooke
    Current Diagnostic Pathology (2003) 9 :48
  • EGFR is dispensable for c-Met-mediated proliferation and survival activities in mouse adult liver oval cells
    A. Martínez-Palacián, G. del Castillo, B. Herrera, M. Fernández, C. Roncero, I. Fabregat, and A. Sánchez
    Cellular Signalling (2012) 24 :505
  • Activation of epidermal growth factor receptor signals induction of nitric oxide synthase-2 in human optic nerve head astrocytes in glaucomatous optic neuropathy
    Bin Liu and Arthur H Neufeld
    Neurobiology of Disease (2003) 13 :109
  • EGFR mutation specific immunohistochemistry is a useful adjunct which helps to identify false negative mutation testing in lung cancer
    Michelle Houang, Loretta Sioson, Adele Clarkson, Nicole Watson, Mahtab Farzin, Christopher W. Toon, Aditi Raut, Sandra A. O’Toole, Wendy A. Cooper, Nick Pavlakis, Scott Mead, Angela Chou, and Anthony J. Gill
    Pathology (2014) 46 :501
  • Dual intracellular signaling by proteolytic cleavage of membrane-anchored heparin-binding EGF-like growth factor
    Daisuke Nanba and Shigeki Higashiyama
    Cytokine & Growth Factor Reviews (2004) 15 :13
  • Apoptosis induced by crocidolite asbestos in human lung epithelial cells involves inactivation of Akt and MAPK pathways
    Aleksander Baldys, Priyadarshini Pande, Tariq Mosleh, Sun-Hee Park, and Ann E. Aust
    Apoptosis (2007) 12 :433
  • Clinical implications of the ErbB/epidermal growth factor (EGF) receptor family and its ligands in ovarian cancer
    Jacqueline M. Lafky, Jason A. Wilken, Andre T. Baron, and Nita J. Maihle
    Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2008) 1785 :232
  • Evidence for Intermolecular Interactions between the Intracellular Domains of the Arabidopsis Receptor-Like Kinase ACR4, Its Homologs and the Wox5 Transcription Factor
    Matthew R. Meyer, Shweta Shah, J. Zhang, Henry Rohrs, A. Gururaj Rao, and Ive De Smet
    PLOS ONE (2015) 10 :e0118861
  • Should there be more molecular staging of head and neck cancer to improve the choice of treatments and thereby improve survival?
    Giovanni Almadori, Francesco Bussu, and Gaetano Paludetti
    Current Opinion in Otolaryngology & Head and Neck Surgery (2008) 16 :117
  • Protease-activated Receptor 2 in Colon Cancer
    Dalila Darmoul, Valérie Gratio, Hélène Devaud, and Marc Laburthe
    Journal of Biological Chemistry (2004) 279 :20927
  • Recent progress in animal modeling of immune inflammatory processes in schizophrenia: Implication of specific cytokines
    Hiroyuki Nawa and Nori Takei
    Neuroscience Research (2006) 56 :2
  • Signal transduction by M3 muscarinic acetylcholine receptor in prostate cancer
    Oncology Letters (2016) 11 :385
  • EGFR and erbB2 mutation status in Japanese lung cancer patients
    Hidefumi Sasaki, Shigeki Shimizu, Katsuhiko Endo, Minoru Takada, Masaaki Kawahara, Hisaichi Tanaka, Akihide Matsumura, Keiji Iuchi, Hiroshi Haneda, Eriko Suzuki, Yoshihiro Kobayashi, Motoki Yano, and Yoshitaka Fujii
    International Journal of Cancer (2006) 118 :180
  • Arachidonic acid release by H2O2mediated proliferation of mouse embryonic stem cells: Involvement of Ca2+/PKC and MAPKs-induced EGFR transactivation
    Sang Hun Lee, Sun Im Na, Jung Sun Heo, Min Hee Kim, Yun Hee Kim, Min Young Lee, Seong Hong Kim, Yun Jung Lee, and Ho Jae Han
    Journal of Cellular Biochemistry (2009) 106 :787
  • Regulation of HER expression and transactivation in human prostate cancer cells by a targeted cytotoxic bombesin analog (AN-215) and a bombesin antagonist (RC-3095)
    Sandra Sotomayor, Laura Muñoz-Moreno, María J. Carmena, Andrew V. Schally, Manuel Sánchez-Chapado, Juan C. Prieto, and Ana M. Bajo
    International Journal of Cancer (2010) 127 :1813
  • EGFR is a pivotal regulator of thrombin-mediated inflammation in primary human nucleus pulposus culture
    Bor-Ren Huang, Tzu-Sheng Chen, Da-Tian Bau, I-Chen Chuang, Cheng-Fang Tsai, Pei-Chun Chang, and Dah-Yuu Lu
    Scientific Reports (2017) 7 :
  • Receptor-type Protein-tyrosine Phosphatase-κ Regulates Epidermal Growth Factor Receptor Function
    Yiru Xu, Li-Jun Tan, Vladimir Grachtchouk, John J. Voorhees, and Gary J. Fisher
    Journal of Biological Chemistry (2005) 280 :42694
  • Layered double hydroxide nanoparticles promote self-renewal of mouse embryonic stem cells through the PI3K signaling pathway
    Youjun Wu, Rongrong Zhu, Yang Zhou, Jun Zhang, Wenrui Wang, Xiaoyu Sun, Xianzheng Wu, Liming Cheng, Jing Zhang, and Shilong Wang
    Nanoscale (2015) 7 :11102
  • Degradation of HER2/neu by ANT2 shRNA suppresses migration and invasiveness of breast cancer cells
    Ji-Young Jang, Yoon-Kyung Jeon, and Chul-Woo Kim
    BMC Cancer (2010) 10 :
  • HER2 Ile655Val polymorphism contributes to breast cancer risk: evidence from 27 case–control studies
    Su Lu, Zhanwei Wang, Hong Liu, and Xishan Hao
    Breast Cancer Research and Treatment (2010) 124 :771
  • Signaling pathways of isoproterenol-induced ERK1/2 phosphorylation in primary cultures of astrocytes are concentration-dependent
    Ting Du, Baoman Li, Hongmei Li, Min Li, Leif Hertz, and Liang Peng
    Journal of Neurochemistry (2010) 115 :1007
  • The mitochondrial transporter SLC25A43 is frequently deleted and may influence cell proliferation in HER2-positive breast tumors
    Elisabet Tina, Breezy Malakkaran Lindqvist, Marike Gabrielson, Zelmina Lubovac, Pia Wegman, and Sten Wingren
    BMC Cancer (2012) 12 :
  • HER2 Codon 655 Polymorphism and Risk of Breast Cancer in African Americans and Whites
    Robert Millikan, Allison Eaton, Kendra Worley, Lorna Biscocho, Elizabeth Hodgson, Wen-Yi Huang, Joseph Geradts, Mary Iacocca, David Cowan, Kathleen Conway, and Lynn Dressler
    Breast Cancer Research and Treatment (2003) 79 :355
  • p38 MAP kinase mediates stress-induced internalization of EGFR: implications for cancer chemotherapy
    Yaara Zwang and Yosef Yarden
    The EMBO Journal (2006) 25 :4195
  • Nimbolide inhibits invasion and migration, and down-regulates uPAR chemokine gene expression, in two breast cancer cell lines
    P. Elumalai, A. Brindha Mercy, R. Arunkamar, G. Sharmila, F. A. Bhat, S. Balakrishnan, P. Raja Singh, and J. Arunakaran
    Cell Proliferation (2014) 47 :540
  • Trastuzumab-induced corneal ulceration: successful no-drug treatment of a “blind” side effect in a case report
    A. Orlandi, R. Fasciani, A. Cassano, A. Agresta, M. A. Calegari, A. Caporossi, and C. Barone
    BMC Cancer (2015) 15 :
  • Prostaglandin E2 transactivates EGF receptor: A novel mechanism for promoting colon cancer growth and gastrointestinal hypertrophy
    Rama Pai, Brian Soreghan, Imre L. Szabo, Meredith Pavelka, Dolgor Baatar, and Andrzej S. Tarnawski
    Nature Medicine (2002) 8 :289
  • A monoclonal antibody recognizing human cancers with amplification/overexpression of the human epidermal growth factor receptor
    A. A. Jungbluth, E. Stockert, H. J. S. Huang, V. P. Collins, K. Coplan, K. Iversen, D. Kolb, T. J. Johns, A. M. Scott, W. J. Gullick, G. Ritter, L. Cohen, M. J. Scanlan, W. K. Cavanee, and L. J. Old
    Proceedings of the National Academy of Sciences (2003) 100 :639
  • Developing Inhibitors of the Epidermal Growth Factor Receptor for Cancer Treatment
    V. Grunwald and M. Hidalgo
    JNCI Journal of the National Cancer Institute (2003) 95 :851
  • Epidermal growth factor receptor-regulated miR-125a-5p - a metastatic inhibitor of lung cancer
    Guofu Wang, Weimin Mao, Shu Zheng, and Jingjia Ye
    FEBS Journal (2009) 276 :5571
  • The epidermal growth factor receptor–tyrosine kinase: A promising therapeutic target in solid tumors
    Christoph A Ritter and Carlos L Arteaga
    Seminars in Oncology (2003) 30 :3
  • Rationale and clinical basis for combining gefitinib (IRESSA, ZD1839) with radiation therapy for solid tumors
    Judith S Ochs
    International Journal of Radiation Oncology*Biology*Physics (2004) 58 :941
  • H2O2-induced transactivation of EGF receptor requires Src and mediates ERK1/2, but not Akt, activation in renal cells
    Shougang Zhougang and Rick G. Schnellmann
    American Journal of Physiology-Renal Physiology (2004) 286 :F858
  • Direct inhibition of EGF receptor activation in vascular endothelial cells by gefitinib ('Iressa', ZD1839)
    Akira Hirata, Hisanori Uehara, Keisuke Izumi, Seiji Naito, Michihiko Kuwano, and Mayumi Ono
    Cancer Science (2004) 95 :614
  • New Insight into the Transcriptional Regulation of Vascular Endothelial Growth Factor Expression in the Endometrium by Estrogen and Relaxin
    Annals of the New York Academy of Sciences (2005) 1041 :233
  • p400 function is required for the adenovirus E1A-mediated suppression of EGFR and tumour cell killing
    M B Flinterman, J S Mymryk, P Klanrit, A F Yousef, S W Lowe, C Caldas, J Gäken, F Farzaneh, and M Tavassoli
    Oncogene (2007) 26 :6863
  • Heterotrimeric G Proteins Directly Regulate MMP14/Membrane Type-1 Matrix Metalloprotease
    Aaron C. Overland and Paul A. Insel
    Journal of Biological Chemistry (2015) 290 :9941
  • Protein tyrosine phosphatases as novel targets in breast cancer therapy
    Caroline E. Nunes-Xavier, Jorge Martín-Pérez, Ari Elson, and Rafael Pulido
    Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2013) 1836 :211
  • The Justy mutant mouse strain produces a spontaneous murine model of salivary gland cancer with myoepithelial and basal cell differentiation
    Andrean L Simons, Ping Lu, Katherine N Gibson-Corley, Robert A Robinson, David K Meyerholz, and John D Colgan
    Laboratory Investigation (2013) 93 :711
  • Structure of the EGF receptor transactivation circuit integrates multiple signals with cell context
    Elizabeth J. Joslin, Harish Shankaran, Lee K. Opresko, Nikki Bollinger, Douglas A. Lauffenburger, and H. Steven Wiley
    Molecular BioSystems (2010) 6 :1293
  • Ligand-induced, p38-dependent Apoptosis in Cells Expressing High Levels of Epidermal Growth Factor Receptor and ErbB-2
    Oleg Tikhomirov and Graham Carpenter
    Journal of Biological Chemistry (2004) 279 :12988
  • Bile acids activate EGF receptor via a TGF-α-dependent mechanism in human cholangiocyte cell lines
    Nathan W. Werneburg, Jung-Hwan Yoon, Hajime Higuchi, and Gregory J. Gores
    American Journal of Physiology-Gastrointestinal and Liver Physiology (2003) 285 :G31
  • Cyclooxygenase-2 in hepatocellular carcinoma
    Tong Wu
    Cancer Treatment Reviews (2006) 32 :28
  • Copy number increase of HER-2 in colorectal cancers
    Oncology Letters (2011) 2 :331
  • Growth factors and their relationship to neoplastic and paraneoplastic disease
    R.A. Badawi, J. Birns, T. Watson, and L. Kalra
    European Journal of Internal Medicine (2005) 16 :83
  • Cyclooxygenase-2 and Epidermal Growth Factor Receptor: Pharmacologic Targets for Chemoprevention
    Andrew J. Dannenberg, Scott M. Lippman, Jason R. Mann, Kotha Subbaramaiah, and Raymond N. DuBois
    Journal of Clinical Oncology (2005) 23 :254
  • Suppression of EGF-induced tumor cell migration and matrix metalloproteinase-9 expression by capsaicin via the inhibition of EGFR-mediated FAK/Akt, PKC/Raf/ERK, p38 MAPK, and AP-1 signaling
    Yong Pil Hwang, Hyo Jeong Yun, Jae Ho Choi, Eun Hee Han, Hyung Gyun Kim, Gye Yong Song, Kwang-il Kwon, Tae Cheon Jeong, and Hye Gwang Jeong
    Molecular Nutrition & Food Research (2011) 55 :594
  • The use of P53, PTEN, and C-erbB-2 to differentiate uterine serous papillary carcinoma from endometrioid endometrial carcinoma
    N. Macwhinnie and H. Monaghan
    International Journal of Gynecological Cancer (2004) 14 :938
  • The Cell Surface Glycoprotein CUB Domain-containing Protein 1 (CDCP1) Contributes to Epidermal Growth Factor Receptor-mediated Cell Migration
    Ying Dong, Yaowu He, Leonore de Boer, M. Sharon Stack, John W. Lumley, Judith A. Clements, and John D. Hooper
    Journal of Biological Chemistry (2012) 287 :9792
  • Nucleolin inhibitor GroA triggers reduction in epidermal growth factor receptor activation: Pharmacological implication for glial scarring after spinal cord injury
    Yona Goldshmit, Sari Schokoroy Trangle, Fabian Afergan, Tal Iram, and Ronit Pinkas-Kramarski
    Journal of Neurochemistry (2016) 138 :845
  • Hypertonic induction of COX-2 expression in renal medullary epithelial cells requires transactivation of the EGFR
    Hongyu Zhao, Wei Tian, Cynthia Tai, and David M. Cohen
    American Journal of Physiology-Renal Physiology (2003) 285 :F281
  • Role for EPS8 in squamous carcinogenesis
    Huixin Wang, Vyomesh Patel, Hiroshi Miyazaki, J.Silvio Gutkind, and W.Andrew Yeudall
    Carcinogenesis (2009) 30 :165
  • Cardiotoxicity associated with targeted cancer therapies
    ZI CHEN and DI AI
    Molecular and Clinical Oncology (2016) 4 :675
  • Biologically Targeted Treatment of Non–Small-Cell Lung Cancer: Focus on Epidermal Growth Factor Receptor
    Ronald B. Natale
    Clinical Lung Cancer (2003) 5 :S11
  • Src-mediated Inter-receptor Cross-talk between the Na+/K+-ATPase and the Epidermal Growth Factor Receptor Relays the Signal from Ouabain to Mitogen-activated Protein Kinases
    Michael Haas, Haojie Wang, Jiang Tian, and Zijian Xie
    Journal of Biological Chemistry (2002) 277 :18694
  • Epiregulin promotes proliferation and migration of renal proximal tubular cells
    Shougang Zhuang, Yan Yan, Rebecca A. Daubert, and Rick G. Schnellmann
    American Journal of Physiology-Renal Physiology (2007) 293 :F219
  • A systematic profile of clinical inhibitors responsive to EGFR somatic amino acid mutations in lung cancer: implication for the molecular mechanism of drug resistance and sensitivity
    Xinghao Ai, Yingjia Sun, Haidong Wang, and Shun Lu
    Amino Acids (2014) 46 :1635
  • The EGFR signalling system in the liver: from hepatoprotection to hepatocarcinogenesis
    Carmen Berasain and Matías A. Avila
    Journal of Gastroenterology (2014) 49 :9
  • Biologic and therapeutic role of HER2 in cancer
    Sylvie Ménard, Serenella Marja Pupa, Manuela Campiglio, and Elda Tagliabue
    Oncogene (2003) 22 :6570
  • Inhibition of proliferation and induction of apoptosis in breast cancer cells by the epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor ZD1839 (‘Iressa’) is independent of EGFR expression level
    Manuela Campiglio, Alberta Locatelli, Clelia Olgiati, Nicola Normanno, Giulia Somenzi, Lucia Viganò, Marzia Fumagalli, Sylvie Ménard, and Luca Gianni
    Journal of Cellular Physiology (2004) 198 :259
  • The expression of EGFR, HER2 and EpCam in Head and Neck squamous cell carcinomas
    V. H. Schartinger, J. Schmutzhard, M. Wurm, I. M. Schwentner, P. Obrist, W. Oberaigner, and G. M. Sprinzl
    memo - Magazine of European Medical Oncology (2009) 2 :45
  • Therapeutic Approaches to Target Cancer Stem Cells
    Arlhee Diaz and Kalet Leon
    Cancers (2011) 3 :3331
  • HER2 Polymorphisms and Breast Cancer in Tunisian Women
    Imen Kallel, Najla Kharrat, Suad Al-fadhly, Maha Rebai, Abdelmajid Khabir, Tahia Sallemi Boudawara, and Ahmed Rebaï
    Genetic Testing and Molecular Biomarkers (2010) 14 :29
  • Emerging therapeutic targets in schwannomas and other merlin-deficient tumors
    Sylwia Ammoun and C. Oliver Hanemann
    Nature Reviews Neurology (2011) 7 :392
  • Laminin-1 and epidermal growth factor family members co-stimulate fetal pancreas cell proliferation and colony formation
    Fang-Xu Jiang and Leonard C. Harrison
    Differentiation (2005) 73 :45
  • The Combination of Serenoa Repens, Selenium and Lycopene is More Effective Than Serenoa Repens Alone to Prevent Hormone Dependent Prostatic Growth
    Domenica Altavilla, Alessandra Bitto, Francesca Polito, Natasha Irrera, Herbert Marini, Salvatore Arena, Vincenzo Favilla, Francesco Squadrito, Giuseppe Morgia, and Letteria Minutoli
    The Journal of Urology (2011) 186 :1524
  • IκBαM suppresses angiogenesis and tumorigenesis promoted by a constitutively active mutant EGFR in human glioma cells
    Jian Liang Wu, Tatsuya Abe, Ryo Inoue, Minoru Fujiki, and Hidenori Kobayashi
    Neurological Research (2004) 26 :785
  • Bovine sperm acrosome reaction induced by G protein-coupled receptor agonists is mediated by epidermal growth factor receptor transactivation
    Nir Etkovitz, Yitshak Tirosh, Reut Chazan, Yael Jaldety, Limor Daniel, Sara Rubinstein, and Haim Breitbart
    Developmental Biology (2009) 334 :447
  • Mechanisms of apoptosis in ovarian cancer: The small molecule targeting
    N Ubanako Philemon, Choene Mpho, and Motadi Lesetja
    International Journal of Medicine and Medical Sciences (2015) 7 :46
  • Role of GPCR (mu-opioid)–receptor tyrosine kinase (epidermal growth factor) crosstalk in opioid-induced hyperalgesic priming (type II)
    Dionéia Araldi, Luiz F. Ferrari, and Jon D. Levine
    PAIN (2018) 159 :864
  • Different classes of EGFR inhibitors may have different potential to improve local tumour control after fractionated irradiation: a study on C225 in FaDu hSCC
    M. Krause, C. Schütze, C. Petersen, N. Pimentel, F. Hessel, A. Harstrick, and M. Baumann
    Radiotherapy and Oncology (2005) 74 :109
  • In Utero Exposure to Low-Dose Alcohol Induces Reprogramming of Mammary Development and Tumor Risk in MMTV-erbB-2 Transgenic Mice
    Zhikun Ma, Amanda Blackwelder, Harry Lee, Ming Zhao, and Xiaohe Yang
    International Journal of Molecular Sciences (2015) 16 :7655
  • ErbB3 mRNA Expression Correlated with Specific Clinicopathologic Features of Japanese Lung Cancers
    Osamu Kawano, Hidefumi Sasaki, Katsuhiko Endo, Eriko Suzuki, Hiroshi Haneda, Haruhiro Yukiue, Yoshihiro Kobayashi, Motoki Yano, and Yoshitaka Fujii
    Journal of Surgical Research (2008) 146 :43
  • Molecular mechanisms of pancreatic cancer and potential targets of treatment
    Ursula Aho, Xia Zhao, Matthias Löhr, and Roland Andersson
    Scandinavian Journal of Gastroenterology (2007) 42 :279
  • EGFR/erB-1, HER2/erB-2, CK7, LP34, Ki67 and P53 expression in preneoplastic lesions of bronchial epithelium: an immunohistochemical and genetic study
    Vítor Sousa, Joana Espírito Santo, Maria Silva, Teresa Cabral, Ana Maria Alarcão, Ana Gomes, Patrícia Couceiro, and Lina Carvalho
    Virchows Archiv (2011) 458 :571
  • Epidermal growth factor receptor is a cellular receptor for human cytomegalovirus
    Xin Wang, Shu-Mei Huong, Marie L. Chiu, Nancy Raab-Traub, and Eng-Shang Huang
    Nature (2003) 424 :456
  • Phorbol 12-Myristate 13-Acetate Induces Epidermal Growth Factor Receptor Transactivation via Protein Kinase Cδ/c-Src Pathways in Glioblastoma Cells
    Samson Amos, Patrick M. Martin, Gregory A. Polar, Sarah J. Parsons, and Isa M. Hussaini
    Journal of Biological Chemistry (2005) 280 :7729
  • SRC family kinases in cell volume regulation
    David M. Cohen
    American Journal of Physiology-Cell Physiology (2005) 288 :C483
  • Role of HER2/HER3 co-receptor in breast carcinogenesis
    Tzong-Der Way and Jen-Kun Lin
    Future Oncology (2005) 1 :841
  • Epidermal growth factor receptor inhibitors in the treatment of non-small cell lung cancer
    Sofia Agelaki and Vassilis Georgoulias
    Expert Opinion on Emerging Drugs (2005) 10 :855
  • Regulation of the sperm EGF receptor by ouabain leads to initiation of the acrosome reaction
    Limor Daniel, Nir Etkovitz, Shirel Rosenwasser Weiss, Sara Rubinstein, Debby Ickowicz, and Haim Breitbart
    Developmental Biology (2010) 344 :650
  • The Epidermal Growth Factor Receptor and Its Ligands in Cardiovascular Disease
    Nader Makki, Kristina Thiel, and Francis Miller
    International Journal of Molecular Sciences (2013) 14 :20597
  • Enhancement of Epidermal Growth Factor Receptor-degradation Pathway in Acquired Gefitinib-resistant Human Non-small Cell Lung Cancer Cell Lines
    Toshimitsu YAMAOKA, Tohru OHMORI, Fumiko INOUE, Tsuyoki KADOFUKU, Koichi ANDO, Hiroo ISHIDA, Takamichi HOSAKA, Takao SHIRAI, Masanori MATSUDA, Munehide NODA, Takashi HIROSE, Naoya HORICHI, Kazuto NISHIO, Nagahiro SAIJO, Carlos L. ARTEAGA, Toshio KUROKI, Mitsuru ADACHI, and Takeshi KAWAGUCHI
    The Showa University Journal of Medical Sciences (2004) 16 :147
  • Permissive effect of EGFR-activated pathways on RVI and their anti-apoptotic effect in hypertonicity-exposed mIMCD3 cells
    Alejandro Ruiz‑Martínez, Erika Vázquez‑Juárez, Gerardo Ramos‑Mandujano, and Herminia Pasantes‑Morales
    Bioscience Reports (2011) 31 :489
  • p53 deficiency provokes urothelial proliferation and synergizes with activated Ha-ras in promoting urothelial tumorigenesis
    Jing Gao, Hong-Ying Huang, Joanne Pak, Jin Cheng, Zhong-Ting Zhang, Ellen Shapiro, Angel Pellicer, Tung-Tien Sun, and Xue-Ru Wu
    Oncogene (2004) 23 :687
  • Nimotuzumab combined with radiotherapy reduces primary tumor and nodal volume in advanced undifferentiated nasopharyngeal carcinoma
    Soehartati GONDHOWIARDJO, Abdul MUTHALIB, Siti KHOTIMAH, and Andhika RACHMAN
    Asia-Pacific Journal of Clinical Oncology (2009) 5 :175
  • Secretion of IL-13 by Airway Epithelial Cells Enhances Epithelial Repair via HB-EGF
    Sima Allahverdian, Norihiro Harada, Gurpreet K. Singhera, Darryl A. Knight, and Delbert R. Dorscheid
    American Journal of Respiratory Cell and Molecular Biology (2008) 38 :153
  • Dependence of Peroxisome Proliferator-activated Receptor Ligand-induced Mitogen-activated Protein Kinase Signaling on Epidermal Growth Factor Receptor Transactivation
    Olivia S. Gardner, Brian J. Dewar, H. Shelton Earp, James M. Samet, and Lee M. Graves
    Journal of Biological Chemistry (2003) 278 :46261
  • HER2 codon 655 polymorphism is associated with advanced uterine cervical carcinoma
    Łukasz Kruszyna, Margarita Lianeri, Andrzej Roszak, and Paweł P. Jagodziński
    Clinical Biochemistry (2010) 43 :545
  • Trisomy chromosome 5 is a recurrent cytogenetic lesion in mammary tumors from parous MMTV-erbB-2 transgenic mice
    Oncology Letters (2011) 2 :1077
  • Growth factors, cytokines and their receptors as downstream targets of arylhydrocarbon receptor (AhR) signaling pathways
    Thomas Haarmann-Stemmann, Hanno Bothe, and Josef Abel
    Biochemical Pharmacology (2009) 77 :508
  • Evaluation of the Prognostic and Predictive Value of HER-1/EGFR in Breast Cancer Patients Participating in a Randomized Study with Dose-Dense Sequential Adjuvant Chemotherapy
    Olympia Tzaida, Helen Gogas, Urania Dafni, Aspasia Kyroudi, Irene Papaspyrou, Vasiliki Kyriakou, Vasiliki Malamou-Mitsi, Maria Alamani, Chrisoula Skopa, Ioannis Kostopoulos, Efstathios Kastritis, Dimitrios Pectasides, Evangelos Briasoulis, Haralabos P. Kalofonos, Gerasimos Aravantinos, George Fountzilas, and Petroula Arapantoni-Dadioti
    Oncology (2007) 72 :388
  • Advances of Targeted Therapy in Treatment of Unresectable Metastatic Colorectal Cancer
    Suk-young Lee and Sang Cheul Oh
    BioMed Research International (2016) 2016 :1
  • Clinical relevance of molecular markers in lung cancer
    P. Iyengar and M.-S. Tsao
    Surgical Oncology (2002) 11 :167
  • Canonical and new generation anticancer drugs also target energy metabolism
    Sara Rodríguez-Enríquez, Juan Carlos Gallardo-Pérez, Ileana Hernández-Reséndiz, Alvaro Marín-Hernández, Silvia C. Pacheco-Velázquez, Sayra Y. López-Ramírez, Franklin D. Rumjanek, and Rafael Moreno-Sánchez
    Archives of Toxicology (2014) 88 :1327
  • Role of EGF receptor ligands in TCDD-induced EGFR down-regulation and cellular proliferation
    Christina M. Campion, Sandra Leon Carrion, Gayatri Mamidanna, Carrie Hayes Sutter, Thomas R. Sutter, and Judith A. Cole
    Chemico-Biological Interactions (2016) 253 :38
  • Radiosensitisation of U87MG brain tumours by anti-epidermal growth factor receptor monoclonal antibodies
    A Diaz Miqueli, J Rolff, M Lemm, I Fichtner, R Perez, and E Montero
    British Journal of Cancer (2009) 100 :950
  • HoxA10 Induces Proliferation in Human Prostate Carcinoma PC-3 Cell Line
    Baoxiu Li, Xiaofei Cao, Chengyin Weng, Yong Wu, Xisheng Fang, Xiaoshi Zhang, and Guolong Liu
    Cell Biochemistry and Biophysics (2014) 70 :1363
  • Gefitinib Cytotoxicity in Non-small Cell Lung Cancer Cells is Enhanced by Low Dose Cisplatin Due to Ligand-independent EGFR Autophosphorylation
    Takamichi HOSAKA, Tohru OHMORI, Koichi ANDO, Hiroo ISHIDA, Sojiro KUSUMOTO, Tomohide SUGIYAMA, Takao SHIRAI, Kentaro OKUDA, Takashi HIROSE, Tsukasa OHNISHI, Naoya HORICHI, Fumiko INOUE, Nagahiro SAUO, Toshio KUROKI, Toshio NAKADATE, and Mitsuru ADACHI
    The Showa University Journal of Medical Sciences (2007) 19 :155